Orchestra BioMed Receives $6.1 Million Vivasure Acquisition Milestone Payment
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Orchestra BioMed Receives Milestone Payment from Acquisition of Vivasure by Haemonetics
September 15, 2026—Orchestra BioMed Holdings, Inc. announced the receipt of $6.1 million on September 14, 2026, as the first milestone payment in connection with the acquisition of Vivasure Medical Limited by Haemonetics Corporation. According to Orchestra BioMed, this second payment follows the approximately $5 million upfront payment received in January 2026 and brings total cash proceeds received by Orchestra BioMed from the transaction to ap…
Orchestra BioMed Receives $6.1 Million Vivasure Acquisition Milestone Payment
Orchestra BioMed Holdings has received a $6.1 million milestone payment tied to Haemonetics Corporation’s acquisition of Vivasure Medical, bringing the biomedical company’s total cash proceeds from the transaction to approximately $11 million in 2026. The New Hope, Pennsylvania-based company received the latest payment on Sept. 14. It follows approximately $5 million in upfront proceeds received in January, when Haemonetics completed its acquisi…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
